Nephros (NASDAQ:NEPH), Inc., headquartered in South Orange, New Jersey, is a medical technology company specializing in advanced filtration solutions for both healthcare and water purification applications. Its core business centers on the development and commercialization of high-efficiency membrane filters engineered to remove pathogens, endotoxins and other contaminants. Nephros’s products address needs in hemodialysis, continuous renal replacement therapy (CRRT), acute care settings, and point-of-use water treatment for residential, commercial and emergency preparedness markets.
In its medical device segment, Nephros offers the UltraFilter family of dialyzers and hemofilters designed to enhance patient safety by minimizing exposure to bacteria, endotoxins and cytokines during renal replacement procedures. These devices are used by hospitals and dialysis centers to improve clinical outcomes and reduce the risk of inflammation-related complications. The company’s technology platform is also leveraged in on-line production of replacement fluid for CRRT, positioning Nephros as a niche supplier of critical components in intensive care and acute dialysis services.
Complementing its healthcare portfolio, Nephros markets point-of-use water purification systems equipped with patented ultrafiltration membranes that remove viruses, bacteria, protozoa, cysts and colloidal solids down to 15 nanometers in size. These units are deployed in a variety of environments, from portable water treatment pods for disaster relief and large-scale events to residential whole-house filters and commercial building systems. Sales are conducted through direct channels and a network of distributors across North America, Europe, Asia and Latin America.
Founded in the early 2000s, Nephros has grown through continued investment in research and development, regulatory approvals and strategic partnerships. The company maintains manufacturing operations in Ogdensburg, New York, and operates a research facility in South Orange, New Jersey. The leadership team is led by President and Chief Executive Officer Alan S. Weiner, whose experience in medical device innovation and quality management has guided Nephros’s expansion into diverse filtration markets globally.
